This exciting episode is a conversation with David Esposito, President and CEO of ONL Therapeutics!We had the pleasure of hosting David Esposito, a visionary leader in the field of biotechnology as the President and CEO of ONL Therapeutics. Join us as we dive deep into the fascinating world of retinal diseases and explore the future of biotech!In this episode, we covered:- David's inspiring background and journey to becoming a leader in the industry- An insightful overview of ONL Therapeutics and their groundbreaking work in the field of retinal diseases.- The evolving landscape of retinal disease treatment and the remarkable progress made over the years.- The role of artificial intelligence and machine learning in shaping the future of biotechnology.- What's next for ONL Therapeutics?We'd like to thank our sponsors for this episode, Sage Growth Partners, a leading healthcare consultancy, their support enables us to bring you thought-provoking discussions with industry experts. For more information, please go to www.sage-growth.com. Learn more about ONL Therapeutics follow these links: LinkedIn - WebsiteAlso, be sure to follow Slice of Healthcare on our social channels:Website  - LinkedIn - Twitter - YouTube - NewsletterDon't miss out! Subscribe to our YouTube channel to catch all the engaging episodes and stay up-to-date with the latest advancements in biotech: https://www.youtube.com/@UCPuxsHtzFktm1XezuJp-KoA

Ver todos los episodios